BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15328680)

  • 1. Reproducibility of response to nasal lysine-aspirin challenge in patients with aspirin-induced asthma.
    Lee DK; Haggart K; Lipworth BJ
    Ann Allergy Asthma Immunol; 2004 Aug; 93(2):185-8. PubMed ID: 15328680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Montelukast protects against nasal lysine-aspirin challenge in patients with aspirin-induced asthma.
    Lee DK; Haggart K; Robb FM; Lipworth BJ
    Eur Respir J; 2004 Aug; 24(2):226-30. PubMed ID: 15332389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma.
    Ragab S; Parikh A; Darby YC; Scadding GK
    Clin Exp Allergy; 2001 Sep; 31(9):1385-91. PubMed ID: 11591188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal lysine-aspirin administration decreases polyp volume in patients with aspirin-intolerant asthma.
    Ogata N; Darby Y; Scadding G
    J Laryngol Otol; 2007 Dec; 121(12):1156-60. PubMed ID: 17697437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is a positive nasal lysine-aspirin challenge test associated with a more severe phenotype of chronic rhinosinusitis and asthma?
    Vaidyanathan S; Williamson PA; Lipworth BJ
    Am J Rhinol Allergy; 2012; 26(3):e89-93. PubMed ID: 22643934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma.
    Milewski M; Mastalerz L; Nizankowska E; Szczeklik A
    J Allergy Clin Immunol; 1998 May; 101(5):581-6. PubMed ID: 9600492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nasal provocation test with lysine-aspirin in diagnosis of nonallergic rhinitis with eosinophilia].
    Modrzyński M; Mazurek H; Zawisza E
    Otolaryngol Pol; 2006; 60(1):25-31. PubMed ID: 16821537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of nasal inspiratory flow rates in the measurement of aspirin-induced respiratory reactions.
    Celikel S; Stevenson D; Erkorkmaz U; White AA
    Ann Allergy Asthma Immunol; 2013 Oct; 111(4):252-5. PubMed ID: 24054359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acoustic rhinometry in the evaluation of intranasal aspirin challenge].
    Kupczyk M; Kupryś-Lipińska I; Bocheńska-Marciniak M; Kuna P
    Pneumonol Alergol Pol; 2010; 78(2):103-11. PubMed ID: 20306421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary LTE4 is higher after nasal provocation test with L-ASA in bronchial than in only nasal responders.
    Micheletto C; Visconti M; Tognella S; Trevisan F; Dal Negro RW
    Eur Ann Allergy Clin Immunol; 2007 May; 39(5):162-6. PubMed ID: 17626331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in urinary LTE4 and nasal functions following nasal provocation test with ASA in ASA-tolerant and -intolerant asthmatics.
    Micheletto C; Tognella S; Visconti M; Trevisan F; Dal Negro RW
    Respir Med; 2006 Dec; 100(12):2144-50. PubMed ID: 16678396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclinical aspirin sensitivity in subjects with nasal polyposis.
    Killen JW; Wilson JA; Gibson GJ
    Clin Otolaryngol Allied Sci; 2003 Dec; 28(6):539-44. PubMed ID: 14616672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal challenge with aspirin in the diagnosis of aspirin intolerant asthma: evaluation of nasal response by acoustic rhinometry.
    Casadevall J; Ventura PJ; Mullol J; Picado C
    Thorax; 2000 Nov; 55(11):921-4. PubMed ID: 11050260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoxin A4 generation is decreased in aspirin-sensitive patients in lysine-aspirin nasal challenge in vivo model.
    Kupczyk M; Antczak A; Kuprys-Lipinska I; Kuna P
    Allergy; 2009 Dec; 64(12):1746-52. PubMed ID: 19385948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acoustic rhinometry and aspirin nasal challenge in the diagnosis of aspirin-intolerant asthma: clinical finding and safety aspects.
    Muñoz-Cano R; Bartra J; Sanchez-Lopez J; Picado C; Bissinger I; Valero A
    Int Arch Allergy Immunol; 2013; 160(3):307-12. PubMed ID: 23095368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal lysine-aspirin in aspirin-sensitive nasal polyposis: a controlled trial.
    Parikh AA; Scadding GK
    Laryngoscope; 2005 Aug; 115(8):1385-90. PubMed ID: 16094110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Montelukast 10 mg improves nasal function and nasal response to aspirin in ASA-sensitive asthmatics: a controlled study vs placebo.
    Micheletto C; Tognella S; Visconti M; Pomari C; Trevisan F; Dal Negro RW
    Allergy; 2004 Mar; 59(3):289-94. PubMed ID: 14982510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal provocation test (NPT) with aspirin: a sensitive and safe method to diagnose aspirin-induced asthma (AIA).
    Alonso-Llamazares A; Martinez-Cócera C; Domínguez-Ortega J; Robledo-Echarren T; Cimarra-Alvarez M; Mesa del Castillo M
    Allergy; 2002 Jul; 57(7):632-5. PubMed ID: 12100305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mediators of inflammation in nasal lavage from aspirin intolerant patients after aspirin challenge.
    Kupczyk M; Kurmanowska Z; Kupryś-Lipińska I; Bocheńska-Marciniak M; Kuna P
    Respir Med; 2010 Oct; 104(10):1404-9. PubMed ID: 20452758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics.
    Dahlén B; Nizankowska E; Szczeklik A; Zetterström O; Bochenek G; Kumlin M; Mastalerz L; Pinis G; Swanson LJ; Boodhoo TI; Wright S; Dubé LM; Dahlén SE
    Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1187-94. PubMed ID: 9563738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.